thioridazine has been researched along with carboplatin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, HK; Choi, YH; Hyun, JW; Keum, YS; Kim, DE; Kim, S; Kim, SH; Kwon, TK; Lee, SH; Min, KJ; Park, HH; Park, JW; Seo, SU; Woo, SM | 1 |
1 other study(ies) available for thioridazine and carboplatin
Article | Year |
---|---|
Thioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression.
Topics: Breast Neoplasms; Carboplatin; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line; Cell Line, Tumor; Down-Regulation; Glioma; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; NF-E2-Related Factor 2; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Thioridazine; Up-Regulation | 2017 |